Neubauer Markus, Kramer Karina, Neugebauer Johannes, Moser Lukas, Moser Anna, Dammerer Dietmar, Nehrer Stefan
Center for Regenerative Medicine and Orthopedics, Danube University Krems, Dr. Karl-Dorrek-Str. 30, 3500 Krems, Austria.
Department of Orthopedics and Traumatology, Karl Landsteiner University of Health Sciences, University Hospital Krems, Mitterweg 10, 3500 Krems, Austria.
Methods Protoc. 2022 Dec 25;6(1):3. doi: 10.3390/mps6010003.
Adipose-derived mesenchymal stem cells (ASCs) are a promising source for clinical application in regenerative orthopedics. ASCs derived from the infra-patellar fat pad (IFP)-a distinct adipose structure in the knee-show superior regenerative potential compared to subcutaneous-fat-derived cells. Furthermore, it has been shown that blood products enhance ASCs' viability. A major challenge for clinical translation of both ASCs and blood products is the low comparability of obtained data due to non-standardized harvesting, isolation and preparation methods. The aim of this method-paper is to provide reproducible protocols to help standardize basic research in the field to build a sound basis for clinical translation with an emphasize on practicability. The presented protocols include (i) ASC isolation from the IFP, (ii) blood product preparation and (iii) ASC incubation with blood products.
脂肪来源的间充质干细胞(ASCs)是再生骨科临床应用中一种很有前景的细胞来源。来自髌下脂肪垫(IFP)——膝关节中一种独特的脂肪结构——的ASCs与皮下脂肪来源的细胞相比,具有更强的再生潜力。此外,研究表明血液制品可提高ASCs的活力。ASCs和血液制品临床转化面临的一个主要挑战是,由于收获、分离和制备方法不规范,所获数据的可比性较低。本方法论文的目的是提供可重复的方案,以帮助规范该领域的基础研究,为临床转化建立坚实基础,并强调实用性。所介绍的方案包括:(i)从IFP中分离ASCs,(ii)制备血液制品,以及(iii)使ASCs与血液制品共孵育。